AGER1	Advanced Glycation Endproduct Receptor 1
AGEs	Advanced Glycation Endproducts
ALEs	Advanced Lipoxidation Endproducts
BBB	Blood–brain barrier
CD	Cluster of Differentiation
CEL	Nε-(carboxyethyl)-lysine
CML	Nε-(carboxymethyl)-lysine
CNS	Central Nervous System
CSF	Cerebrospinal Fluid
DHAP	Dihydroxyacetone Phosphate
DMTs	Disease Modifying Treatments
EAE	Experimental Autoimmune Encephalomyelitis
EDSS	Expended Disability Status Score
GAP	Glyceraldehyde-3-phosphate
Glo-1	Glyoxalase-1
Glo-2	Glyoxalase-2
GLUT	Glucose Transporter
GO	Glyoxal
GSH	Glutathione
GWAS	Genome-wide Association Studies
HLA	Human Leukocyte Antigen
HMGB	High-Mobility Group B
HNE	4-Hydroxynonenal
IL	Interleukin
MDA	Malondialdehyde
MG-H1	Methylglyoxal-derived Hydroimidazolone 1
MGO	Methylglyoxal
MS	Multiple Sclerosis
NADPH	Nicotinamide Adenine Dinucleotide Phosphate
NAWM	Normal Appearing White Matter
NF-κB	Nuclear Factor-κB
PBMCs	Peripheral Blood Mononuclear Cells
PP-MS	Primary Progressive Multiple Sclerosis
RAGE	Receptor for Advanced Glycation Endproducts
ROS	Reactive Oxygen Species
RR-MS	Relapsing Remitting Multiple Sclerosis
SP-MS	Secondary Progressive Multiple Sclerosis
sRAGE	Soluble Receptor of Advanced Glycation Endproducts
THP	Tetrahydropyrimidine
TNFα	Tumor Necrosis Factor alpha